Equities

TOT BIOPHARM International Co Ltd

TOT BIOPHARM International Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)2.00
  • Today's Change0.00 / 0.00%
  • Shares traded98.80k
  • 1 Year change0.00%
  • Beta0.0958
Data delayed at least 15 minutes, as of Sep 20 2024 08:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments352458153
Total Receivables, Net1436327
Total Inventory1269530
Prepaid expenses192017
Other current assets, total544180
Total current assets693677306
Property, plant & equipment, net712563379
Goodwill, net------
Intangibles, net8.844.655.12
Long term investments2.793.185.07
Note receivable - long term------
Other long term assets9.441515
Total assets1,4261,262710
LIABILITIES
Accounts payable362628
Accrued expenses22210020
Notes payable/short-term debt000
Current portion long-term debt/capital leases4377148
Other current liabilities, total827365
Total current liabilities382275261
Total long term debt30321261
Total debt346290209
Deferred income tax------
Minority interest01.56--
Other liabilities, total545953
Total liabilities739548375
SHAREHOLDERS EQUITY
Common stock2,2972,2971,893
Additional paid-in capital------
Retained earnings (accumulated deficit)(1599)(1570)(1538)
Treasury stock - common------
Unrealized gain (loss)000
Other equity, total(12)(14)(20)
Total equity687714335
Total liabilities & shareholders' equity1,4261,262710
Total common shares outstanding773773615
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.